The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.


Updates from The Motley Fool

Latest updates on Trinity Biotech from Fool.com.


Stock Performance

View Interactive TRIB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Trinity Biotech.
Current Price: $5.55
Prev Close: $5.41
Open: $5.63
Bid: $5.21
Ask: $6.98
Day's Range: $5.27 - $5.65
52wk Range: $5.20 - $13.68
Volume: 39,088
Avg Vol 50,792
Market Cap: $133M
P/E (ttm): 12.88
EPS (ttm): $0.00
Div & Yield: $0.00 (4.1%)

Company Rating

What our community thinks about Trinity Biotech.
CAPS Rating 3 out of 5
 
139 Outperform
10 Underperform
CAPS All Stars
 
18 Outperform
2 Underperform

How do you think Trinity Biotech will perform against the market?



You pick for Trinity Biotech is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ronan O'Caoimh, CEO

22% Approve

Based on 8 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Trinity Biotech.

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers